Movement Alert｜HANSOH PHARMA Falls 3.09% in Regular Trading, Pharmaceutical Sector Broadly Weak

Market Focus

Aug 21

On August 21, HANSOH PHARMA fell 3.09% in regular trading, trading at HK$32.62/share, with turnover of approximately HK$47.16 million.

The decline came amid broad weakness across the pharmaceutical sector, with no company-specific negative catalyst identified. Within the sector, CSPC Pharma fell 3.73%, Hengrui Pharma dropped 2.94%, and Asymchem declined 7.95%, while SBP Group gained 1.76% and Luye Pharma rose 1.17%. The stock had risen 3.34% the prior session following an analyst target price upgrade from CMB International to HK$47.19 with a maintained Buy rating, suggesting partial profit-taking may have contributed to today's pullback.

HANSOH PHARMA is scheduled to release interim results on August 26. The company reported revenue of RMB 15.028 billion with a gross margin of 88.92% in the prior period, and market expectations for revenue growth remain positive ahead of the earnings release.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigrdive.com/news/1169168157"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1169168157\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1169168157?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-08-21 09:50","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1169168157","market":"hk","top_or_hot":-1,"title":"Movement Alert｜HANSOH PHARMA Falls 3.09% in Regular Trading, Pharmaceutical Sector Broadly Weak","media":"Market Focus","content":"<p><p>On August 21, HANSOH PHARMA fell 3.09% in regular trading, trading at HK$32.62/share, with turnover of approximately HK$47.16 million.</p><p>The decline came amid broad weakness across the pharmaceutical sector, with no company-specific negative catalyst identified. Within the sector, CSPC Pharma fell 3.73%, Hengrui Pharma dropped 2.94%, and Asymchem declined 7.95%, while SBP Group gained 1.76% and Luye Pharma rose 1.17%. The stock had risen 3.34% the prior session following an analyst target price upgrade from CMB International to HK$47.19 with a maintained Buy rating, suggesting partial profit-taking may have contributed to today's pullback.</p><p>HANSOH PHARMA is scheduled to release interim results on August 26. The company reported revenue of RMB 15.028 billion with a gross margin of 88.92% in the prior period, and market expectations for revenue growth remain positive ahead of the earnings release.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Movement Alert｜HANSOH PHARMA Falls 3.09% in Regular Trading, Pharmaceutical Sector Broadly Weak</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMovement Alert｜HANSOH PHARMA Falls 3.09% in Regular Trading, Pharmaceutical Sector Broadly Weak\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1054767329\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Market Focus </p>\n<p class=\"h-time\">2026-08-21 09:50</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p><p>On August 21, HANSOH PHARMA fell 3.09% in regular trading, trading at HK$32.62/share, with turnover of approximately HK$47.16 million.</p><p>The decline came amid broad weakness across the pharmaceutical sector, with no company-specific negative catalyst identified. Within the sector, CSPC Pharma fell 3.73%, Hengrui Pharma dropped 2.94%, and Asymchem declined 7.95%, while SBP Group gained 1.76% and Luye Pharma rose 1.17%. The stock had risen 3.34% the prior session following an analyst target price upgrade from CMB International to HK$47.19 with a maintained Buy rating, suggesting partial profit-taking may have contributed to today's pullback.</p><p>HANSOH PHARMA is scheduled to release interim results on August 26. The company reported revenue of RMB 15.028 billion with a gross margin of 88.92% in the prior period, and market expectations for revenue growth remain positive ahead of the earnings release.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"03692","symbol_name":"翰森制药","start_time":0,"source_url":"","article_id":"1169168157","we_media_id":"1054767329","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1169168157","pubTimestamp":1787277046,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Market Focus","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1054767329","head_image":"https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a"},"summary":"On August 21, HANSOH PHARMA fell 3.09% in regular trading, trading at HK$32.62/share, with turnover of approximately HK$47.16 million.The decline came amid broad weakness across the pharmaceutical...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"03692":"翰森制药"},"translate_title":"走势警报|豪森制药常规交易下跌3.09%，医药板块普遍疲软","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"03692":1},"content_text":"On August 21, HANSOH PHARMA fell 3.09% in regular trading, trading at HK$32.62/share, with turnover of approximately HK$47.16 million.The decline came amid broad weakness across the pharmaceutical sector, with no company-specific negative catalyst identified. Within the sector, CSPC Pharma fell 3.73%, Hengrui Pharma dropped 2.94%, and Asymchem declined 7.95%, while SBP Group gained 1.76% and Luye Pharma rose 1.17%. The stock had risen 3.34% the prior session following an analyst target price upgrade from CMB International to HK$47.19 with a maintained Buy rating, suggesting partial profit-taking may have contributed to today's pullback.HANSOH PHARMA is scheduled to release interim results on August 26. The company reported revenue of RMB 15.028 billion with a gross margin of 88.92% in the prior period, and market expectations for revenue growth remain positive ahead of the earnings release.(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"-1","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}